Sammi1723
New Member
Ok then! Thanks for the responses. Appreciate y’all and happy new year!
If Skye, Polaris, or Pacific Wave are reading, we’re open to big sales!It honestly has to be a rough time to be a domestic vendor. They likely made huge MOQ buys paying 3 times what it sells for today in China considering the price cuts. It's got to be hard to move. If they cut the price they are losing money
I'm also thinking about testing some reta ..@PeptideJedi: Damn son
You’ve got me beat —- 2.5 yrs of Tirz in the freezer and I’ve been at goal weight and on maintenance at 5 mg. I’ll never get through it, it seems. Kit of Reta 20 just arrived
I actually thought of this idea myself. Tirzepatide is a weaker GLP-1 agonist for the receptor than natural GLP. whereas Semaglutide is a much stronger agonist than the endogenous peptide. So combining Sema's strong GLP effects with the GIP agonism of Tirz should, in theory, create a great med for diabetes and obesity. Similar to stacking Tirz and Sema. All IMHO, of course. Happy New Year everyone.Just playing devil's advocate. Plenty of people on here discussing and taking peptides that have never completed phase 3 testing. Even Retatrutide has not completed phase 3 testing. What about all those Russian Khavinson peptides, how many of these peptides have gone through any type of approval process?
This is my current stack. I am on 2mg sema on Sunday and 6mg tirz Weds. It is just not cutting it. I am going to bump tirz this week... and maybe add a bit of Cagri next weekI actually thought of this idea myself. Tirzepatide is a weaker GLP-1 agonist for the receptor than natural GLP. whereas Semaglutide is a much stronger agonist than the endogenous peptide. So combining Sema's strong GLP effects with the GIP agonism of Tirz should, in theory, create a great med for diabetes and obesity. Similar to stacking Tirz and Sema. All IMHO, of course. Happy New Year everyone.